Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,185 | 69,519 | 18,362 | 36,632 | 29,408 |
| Marketable Securities | 339,056 | 323,401 | 117,302 | 118,853 | 125,615 |
| TOTAL | $381,300 | $399,371 | $149,468 | $167,040 | $165,146 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,363 | 1,322 | 1,427 | 1,489 | 1,537 |
| TOTAL | $1,363 | $1,322 | $1,427 | $1,489 | $1,537 |
| Total Assets | $382,663 | $400,693 | $150,895 | $168,529 | $166,683 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,711 | 5,611 | 3,799 | 8,529 | 3,142 |
| TOTAL | $13,405 | $13,478 | $15,649 | $21,947 | $14,061 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,018 | 1,100 | 1,181 | 1,260 | 1,337 |
| TOTAL | $1,018 | $1,100 | $1,181 | $1,260 | $1,337 |
| Total Liabilities | $14,423 | $14,578 | $16,830 | $23,207 | $15,398 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 100,029 | 100,029 | 99,582 | 78,419 | 76,688 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -353,339 | -330,805 | -311,580 | -292,049 | -272,490 |
| Other shareholders' equity | -700 | -835 | -413 | -897 | -1,556 |
| TOTAL | $368,240 | $386,115 | $134,065 | $145,322 | $151,285 |
| Total Liabilities And Equity | $382,663 | $400,693 | $150,895 | $168,529 | $166,683 |